statistiche ricercatore

Continente	#
NA - Nord America	1.137
EU - Europa	707
AS - Asia	456
SA - Sud America	57
OC - Oceania	8
AF - Africa	6
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.372

Nazione	#
US - Stati Uniti d'America	1.130
RU - Federazione Russa	274
SG - Singapore	147
PL - Polonia	135
CN - Cina	105
HK - Hong Kong	73
IE - Irlanda	58
SE - Svezia	54
IT - Italia	53
BR - Brasile	42
VN - Vietnam	40
KR - Corea	35
DE - Germania	34
FR - Francia	32
UA - Ucraina	24
IN - India	18
FI - Finlandia	15
GB - Regno Unito	11
AU - Australia	8
JO - Giordania	8
AR - Argentina	7
ES - Italia	7
JP - Giappone	6
PH - Filippine	5
TR - Turchia	4
BD - Bangladesh	3
ID - Indonesia	3
NL - Olanda	3
TW - Taiwan	3
CA - Canada	2
CI - Costa d'Avorio	2
CL - Cile	2
EG - Egitto	2
IQ - Iraq	2
JM - Giamaica	2
MX - Messico	2
BG - Bulgaria	1
BO - Bolivia	1
CH - Svizzera	1
CR - Costa Rica	1
CV - Capo Verde	1
EC - Ecuador	1
EE - Estonia	1
EU - Europa	1
HR - Croazia	1
LV - Lettonia	1
MA - Marocco	1
OM - Oman	1
PE - Perù	1
PK - Pakistan	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
UY - Uruguay	1
VE - Venezuela	1
Totale	2.372

Nome	#
Ingestible capsule for treating gastric infections, in particular for treating H.Pylori infections	285
Synergistic effect of photodynamic therapy at 400 nm and doxycycline against Helicobacter pylori	243
An ingestible capsule for the photodynamic therapy of helicobacter pylori infection	223
Side effects of intra-gastric photodynamic therapy: an in vitro study	193
Optical modelling of the gastric tissue to optimize the phototherapy efficacy against H. pylori infection	171
Helicobacter pylori stool antigen test before and after eradication therapy.	165
Minimally invasive ingestible device to perform anti-bacterial phototherapy in the stomach	159
Ingestible light source for intragastric antibacterial phototherapy: a device safety study on a minipig model	151
Serologic detection of CagA positive Helicobacter pylori infection in a northern Italian population: its association with peptic ulcer disease.	150
Enzyme immunoassay of gastric luminal prostaglandin E2 in duodenal ulcer disease	145
Expression of epidermal growth factor, transforming growth factor-alpha and their receptor in the human oesophagus.	139
Gastric juice immunoreactive epidermal growth factor levels in patients with peptic ulcer disease	130
Helicobacter pylory cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa	126
Helicobacter pylori infection modulates peroxisome proliferator activated receptor gamma (PPARgamma) expression and transcriptional activity.	105
Totale	2.385

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	12	0	0	0	0	0	0	0	0	0	0	4	8
2021/2022	98	4	6	4	7	7	8	0	5	5	4	22	26
2022/2023	239	24	37	19	9	23	40	36	13	27	0	9	2
2023/2024	105	6	9	13	3	10	20	7	14	0	2	12	9
2024/2025	725	19	67	32	124	203	114	1	41	47	28	25	24
2025/2026	583	123	96	42	36	86	22	71	26	31	41	9	0
Totale													2.385